Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings

BACKGROUND: Typhoid fever remains endemic in low- and middle-income countries. Programmatic use of existing vaccines is limited, but upcoming typhoid conjugate vaccines (TCVs) could warrant wider use. We evaluated the cost-effectiveness of five TCV delivery strategies in three urban areas (Delhi and...

Descripción completa

Detalles Bibliográficos
Autores principales: Antillón, Marina, Bilcke, Joke, Paltiel, A. David, Pitzer, Virginia E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462484/
https://www.ncbi.nlm.nih.gov/pubmed/28527687
http://dx.doi.org/10.1016/j.vaccine.2017.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462484/
https://www.ncbi.nlm.nih.gov/pubmed/28527687
http://dx.doi.org/10.1016/j.vaccine.2017.05.001

Ejemplares similares